Which Social Media Platforms Provide the Most Informative Data for Monitoring the Opioid Crisis?

Kristy A. Carpenter; Anna T. Nguyen; Delaney A. Smith; Issah A. Samori; Keith Humphreys; Anna Lembke; Mathew V. Kiang; Johannes C. Eichstaedt; Russ B. Altman

doi:10.1101/2024.07.06.24310035

ABSTRACT

Background and Aims Social media can provide real-time insight into trends in substance use, addiction, and recovery. Prior studies have leveraged data from platforms such as Reddit and X (formerly Twitter), but evolving policies around data access have threatened their usability in opioid overdose surveillance systems. Here, we evaluate the potential of a broad set of platforms to detect emerging trends in the opioid crisis.

Design We identified 72 online platforms with a substantial global user base or prior citations in opioid-related research. We evaluated each platform’s fit with our definition of social media, size of North American user base, and volume of opioid-related discourse. We created a shortlist of 11 platforms that met our criteria. We documented basic characteristics, volume and nature of opioid discussion, official policies regulating drug-related discussion, and data accessibility of shortlisted platforms.

Setting USA and Canada.

Measurements We quantified the volume of opioid discussion by number of platform-specific Google search hits for opioid terms. We captured informal language by including slang generated using a large language model. We report the number of opioid-related hits and proportion of opioid-related hits to hits for common nouns.

Findings We found that TikTok, YouTube, and Facebook have the most potential for use in opioid-related surveillance. TikTok and Facebook have the highest relative amount of drug-related discussions. Language on TikTok was predominantly informal. Many platforms offer data access tools for research, but changing company policies and user norms create instability. The demographics of users varies substantially across platforms.

Conclusions Social media data sources hold promise for detecting trends in opioid use, but researchers must consider the utility, accessibility, and stability of data on each platform. A strategy mixing several platforms may be required to cover all demographics suffering in the epidemic.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work supported by: NIH DA057598; Microsoft Accelerating Foundation Models Research Initiative; NSF GRFP DGE-1656518 to KAC; NIH NHLBI T32HL151323 to ATN; DAS is supported by the Stanford Biochemistry Department and NSF GRFP 2019286895; Stanford Summer First Fellowship to IAS; Sarafan ChEM-H CBI Program Award to IAS; KH is supported by a Senior Research Career Scientist Award (RCS 04-141-3) from the Department of Veterans Affairs Health System Research Service; JCE, RBA, AL are supported by the Stanford Institute for Human-Centered AI; RBA is supported by the Chan Zuckerberg Biohub.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Public social media posts indexed by Google

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes